p21-activated Kinase 6 (PAK6) Inhibits Prostate Cancer Growth via Phosphorylation of Androgen Receptor and Tumorigenic E3 Ligase Murine Double Minute-2 (Mdm2)

Molecular Alterations during Progression of Prostate Cancer to Androgen Independence

(2011) P. Saraon et al.   CLINICAL CHEMISTRY

Androgen receptor levels are upregulated by Akt in prostate cancer

(2011) S. Ha et al.   ENDOCRINE-RELATED CANCER

Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival

(2011) Emma Hörnberg et al.   PLoS One

New and emerging agents for the treatment of castration-resistant prostate cancer

(2011) Celestia S. Higano et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

PAK as a therapeutic target in gastric cancer

(2010) Xiaodong Li et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Signalling to cancer cell invasion through PAK family kinases

(2010) Andrew Whale   Frontiers in Bioscience-Landmark

Phosphorylation and Activation of Androgen Receptor by Aurora-A

(2010) Shao-Kun Shu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

PAK signaling in oncogenesis

(2009) P R Molli et al.   ONCOGENE

Knockdown of p21-activated Kinase 6 Inhibits Prostate Cancer Growth and Enhances Chemosensitivity to Docetaxel

(2009) Xingqiao Wen et al.   UROLOGY

Site-specific Androgen Receptor Serine Phosphorylation Linked to Epidermal Growth Factor-dependent Growth of Castration-recurrent Prostate Cancer

(2008) Liliana A. Ponguta et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins

(2008) Ramneet Kaur et al.   PROSTATE